Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Capital Leases (2016 - 2021)

Pharma-Bio Serv's Capital Leases history spans 11 years, with the latest figure at $52430.0 for Q1 2021.

  • For Q1 2021, Capital Leases fell 18.37% year-over-year to $52430.0; the TTM value through Jan 2021 reached $52430.0, down 18.37%, while the annual FY2020 figure was $55439.0, 17.35% down from the prior year.
  • Capital Leases reached $52430.0 in Q1 2021 per PBSV's latest filing, down from $55439.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $72668.0 in Q2 2019 to a low of $20206.0 in Q2 2017.
  • Average Capital Leases over 5 years is $53923.1, with a median of $56397.0 recorded in 2018.
  • Peak YoY movement for Capital Leases: skyrocketed 162.12% in 2018, then decreased 24.61% in 2019.
  • A 5-year view of Capital Leases shows it stood at $59795.0 in 2017, then fell by 23.03% to $46027.0 in 2018, then surged by 45.74% to $67079.0 in 2019, then dropped by 17.35% to $55439.0 in 2020, then decreased by 5.43% to $52430.0 in 2021.
  • Per Business Quant, the three most recent readings for PBSV's Capital Leases are $52430.0 (Q1 2021), $55439.0 (Q4 2020), and $58408.0 (Q3 2020).